MAPT and Alzheimer disease: Important variations in DNA methylation profiles of the APP, microtubule-associated protein tau, and GSK3B were also discovered, along with PSEN1, beta-secretase 1 precursor, or apolipoprotein E. Many studies have reported genetic variants linked to enhanced AD susceptibility, but do not limit many other promoters.